ArticleMolecular cytogenetics2026
Clinical diagnosis and genetic analysis of a rare case of Duchenne muscular dystrophy and spinal muscular atrophy.
Article in Molecular cytogenetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveTo explore the clinical and genetic features both spinal muscular atrophy (SMA) and Duchenne muscular dystrophy (DMD) diagnosed in a child.
methodsA child was diagnosed with SMA combined with a duplication of exons 2-20 in the DMD gene at another hospital. Optical genome mapping (OGM) was employed to assess whether the duplication of exons 2-20 in the DMD gene affected its function.
resultsThe patient was a 19-month-old boy who presented with delayed motor development and generalised hypotonia. Whole exome sequencing (WES) and multiplex ligation-dependent probe amplification (MLPA) performed at another hospital indicated that the patient had a hemizygous duplication involving exons 2-20 of the DMD gene, which was maternally inherited. Additionally, the patient had a homozygous deletion of SMN1 exons 7 and 8 (zero copies) and 3 copies of SMN2 exons 7 and 8. Both parents carried one copy of SMN1. Additionally, the mother harboured two copies of SMN2, whereas the father had three copies of SMN2. OGM analysis revealed a tandem duplication of exons 2-20 in the DMD gene in the patient and his mother.
conclusionWe describe a rare case of a patient with concomitant DMD and SMA. When a patient's phenotype cannot be explained by a single genetic disorder, the possibility of multiple genetic disorders coexisting due to multiple mutations must be considered. OGM is a valuable diagnostic tool for determining the pathogenicity of DMD exon duplications, as it can definitively establish their genomic location and structure.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.